Featured Research

from universities, journals, and other organizations

Nanostructures Improve Bone Response To Titanium Implants

Date:
July 3, 2008
Source:
International & American Association for Dental Research
Summary:
Titanium implants were successfully introduced by P.-I. Brånemark and co-workers in 1969 for the rehabilitation of edentulous jaws. After 40 years of research and development, titanium is currently the most frequently used biomaterial in oral implantology, and titanium-based materials are often used to replace lost tissue in several parts of the body.

Titanium implants were successfully introduced by P.-I. Brånemark and co-workers in 1969 for the rehabilitation of edentulous jaws. After 40 years of research and development, titanium is currently the most frequently used biomaterial in oral implantology, and titanium-based materials are often used to replace lost tissue in several parts of the body.

There are some alternatives to modulating the body's response after implant placement. Modifying the implant surface topography has been a successful path among the scientific community, with the primary goals of achieving faster bone contact to the implant surface and more predictable results after several years.

A team of Swedish researchers is reporting the results of experiments that focused on structures, so-called 'nanostructures', one million times smaller than a Canadian one-dollar coin. The results demonstrated enhanced bone response to dental implants modified with such small structures as soon as 4 weeks after implant placement.

Modifying the size and distribution of the nanostructures at the implant surface may not only represent a faster and more reliable treatment for patients, but also may help in understanding the sequence of events at the body-implant interface and provide guidelines for the further development of osseointegrated implant surfaces.

This is a summary of an abstract entitled "Nano-size Structures and Enhanced Bone Formation", by L. Meirelles et al., of the University of Göteborg, Sweden, to be presented July 3, 2008 in Toronto, ON, Canada, during the 86th General Session of the International Association for Dental Research.


Story Source:

The above story is based on materials provided by International & American Association for Dental Research. Note: Materials may be edited for content and length.


Cite This Page:

International & American Association for Dental Research. "Nanostructures Improve Bone Response To Titanium Implants." ScienceDaily. ScienceDaily, 3 July 2008. <www.sciencedaily.com/releases/2008/07/080703113634.htm>.
International & American Association for Dental Research. (2008, July 3). Nanostructures Improve Bone Response To Titanium Implants. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2008/07/080703113634.htm
International & American Association for Dental Research. "Nanostructures Improve Bone Response To Titanium Implants." ScienceDaily. www.sciencedaily.com/releases/2008/07/080703113634.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins